UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

The New England journal of medicine, 2014-11, Vol.371 (21), p.1963-1971

2014

Volltextzugriff (PDF)

Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196

Journal of clinical oncology, 2004-12, Vol.22 (23), p.4683-4638

2004

Volltextzugriff (PDF)

Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

Journal of clinical oncology, 2004-04, Vol.22 (7), p.1180-1187

2004

Volltextzugriff (PDF)

Improving women's health services in the Russian Federation: Results of a pilot project

1998

Volltextzugriff (PDF)

Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7508-7508

2012

Volltextzugriff (PDF)

Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma

Annals of allergy, asthma, & immunology, 2020-02, Vol.124 (2), p.190-196

2020

Volltextzugriff (PDF)

Rocilinostat (ACY-1215), a Selective HDAC6 Inhibitor, Alone and in Combination with Bortezomib in Multiple Myeloma: Preliminary Results From the First-in-Humans Phase I/II Study

Blood, 2012-11, Vol.120 (21), p.4061-4061

2012

Volltextzugriff (PDF)

Efficacy and safety of crizotinib in patients with advanced c-MET -amplified non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8001-8001

2014

Volltextzugriff (PDF)

Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590

Lung cancer (Amsterdam, Netherlands), 2005-06, Vol.48 (3), p.389-397

2005

Volltextzugriff (PDF)

Influence of Experience, Grade Level, and Subject Area on Teachers' Assessment Practices

The Journal of educational research (Washington, D.C.), 1998-07, Vol.91 (6), p.323-330

1998

Volltextzugriff (PDF)

Efficacy and safety of crizotinib in patients with advanced ROS1 -rearranged non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8032-8032

2013

Volltextzugriff (PDF)

A life well lived; lessons my father taught me

The Presbyterian record (Montreal), 2015-11, p.21

Stephenson, Patricia

2015

Volltextzugriff (PDF)

EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2006-06, Vol.1 (5), p.406-412

2006

Volltextzugriff (PDF)

The survival of Shigella sonnei in shredded cabbage

Journal of food protection, 1990-07, Vol.53 (7), p.558-561

1990

Volltextzugriff (PDF)

Content of academic essays

Nurse education today, 1985, Vol.5 (2), p.81-87

Stephenson, Patricia M

1985

Volltextzugriff (PDF)

Commentary: the public health consequences of restricted induced abortion--lessons from Romania

American journal of public health (1971), 1992-10, Vol.82 (10), p.1328-1331

1992

Volltextzugriff (PDF)

O-52 ECOG 1599: Randomized phase II study of paclitaxel/carboplatin vs cisplatin/gemcitabine in performance status (PS) 2 patients with treatment-naive advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S18-S18

2003

Volltextzugriff (PDF)

EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2006-06, Vol.1 (5), p.406-412

2006

Volltextzugriff (PDF)

Stephenson and Wagner Respond

American journal of public health (1971), 1993-08, Vol.83 (8), p.1181-1181

1993

Volltextzugriff (PDF)

Look twice

European journal of public health, 1993, Vol.3 (3), p.151-152

1993

Volltextzugriff (PDF)

Variation in cesarean section rates among hospitals in Washington State

American journal of public health (1971), 1993-08, Vol.83 (8), p.1109-1112

1993

Volltextzugriff (PDF)

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)

Cancer, 2001-11, Vol.92 (10), p.2517-2522

2001

Volltextzugriff (PDF)

P-628 Trastuzumab in combination with paclitaxel/carboplatin in advanced non-small cell lung cancer: Final report of ECOG 2598

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S251-S251

2003

Volltextzugriff (PDF)

A Phase II trial of cisplatin plus WR‐2721 (amifostine) for metastatic breast carcinoma

Cancer, 2001-11, Vol.92 (10), p.2517-2522

2001

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(215)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(241)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(90)
Humans
(81)
Female
(56)
Male
(49)
Biological And Medical Sciences
(48)
Adult
(39)
Social Sciences
(39)
Middle Aged
(36)
Education
(32)
Medical Sciences
(29)
Aged
(28)
Digital Media & Learning
(28)
Media Studies
(28)
Fundamental And Applied Biological Sciences. Psychology
(21)
Oncology
(20)
Adolescent
(19)
Digital Humanities & New Media
(18)
Game Studies
(18)
Games In Education
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alzheimer's & Dementia
(9)
Journal Of Clinical Oncology
(9)
Stroke
(7)
Addiction
(4)
Lung Cancer
(4)
Plos One
(4)
American Journal Of Public Health
(3)
Bioorganic & Medicinal Chemistry Letters
(3)
Cancer
(3)
Contemporary Economic Policy
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study

Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196

Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

Improving women's health services in the Russian Federation: Results of a pilot project

Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement

Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma

Rocilinostat (ACY-1215), a Selective HDAC6 Inhibitor, Alone and in Combination with Bortezomib in Multiple Myeloma: Preliminary Results From the First-in-Humans Phase I/II Study

Efficacy and safety of crizotinib in patients with advanced c-MET -amplified non-small cell lung cancer (NSCLC)

Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590

Influence of Experience, Grade Level, and Subject Area on Teachers' Assessment Practices

Efficacy and safety of crizotinib in patients with advanced ROS1 -rearranged non-small cell lung cancer (NSCLC)

A life well lived; lessons my father taught me

EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer

The survival of Shigella sonnei in shredded cabbage

Content of academic essays

Commentary: the public health consequences of restricted induced abortion--lessons from Romania

O-52 ECOG 1599: Randomized phase II study of paclitaxel/carboplatin vs cisplatin/gemcitabine in performance status (PS) 2 patients with treatment-naive advanced NSCLC

EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer

Stephenson and Wagner Respond

Look twice

Variation in cesarean section rates among hospitals in Washington State

A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)

P-628 Trastuzumab in combination with paclitaxel/carboplatin in advanced non-small cell lung cancer: Final report of ECOG 2598

A Phase II trial of cisplatin plus WR‐2721 (amifostine) for metastatic breast carcinoma

Suchergebnisse filtern